Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 11.735% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CC(NC1c2ccccc2-c2ccccc21)c1ccccc1
b) Cc1ccc(CNc2cccnc2)cc1
c) Cc1ccc(/C=N/NC(=O)C2(C)CC2(Br)Br)cc1
Answer: c. Cc1ccc(/C=N/NC(=O)C2(C)CC2(Br)Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(/C=N/NC(=O)C2(C)CC2(Br)Br)cc1
Cc1ccc(/C=N/NC(=O)C2(C)CC2(Br)Br)cc1
2,2-dibromo-1-methyl-N-[(E)-(4-methylphenyl)methylideneamino]cyclopropane-1-carboxamide